Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
35 Oak Holdings is a private investment firm and family office headquartered in Toronto, Canada, with a strategic focus on the healthcare, life sciences, and cannabis industries. Led by CEO Michael Wiener, the firm provides capital and operational guidance to growth-stage companies and has been a significant participant in the North American cannabis market. 35 Oak Holdings notably served as the sponsor for 35 Oak Healthcare Acquisitions Corp., a special purpose acquisition company (SPAC) that targeted the healthcare sector. The firm is also recognized for its involvement in major industry transactions, including its role as a key shareholder in MYM Nutraceuticals prior to its acquisition by IM Cannabis Corp. In addition to its healthcare interests, 35 Oak Holdings maintains a diversified investment portfolio spanning food technology, pet nutrition, and real estate.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 35 Oak Holdings.